This content is restricted.
Brief
The document provides historical information from 2014 about medicines and their potential risks, interactions, and effects. The guidance by the Medicines and Healthcare Products Regulatory Agency (MHRA) covers four key areas: risk of suicidal behavior, withdrawal reactions, use in pregnancy, and interactions with other medications such as tamoxifen and methylthioninium chloride. This information is now outdated and should be supplemented with more recent data from the MHRA's products page.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
